Sponsor:
Meharry Medical College
Code:
NCT04380623
Conditions
Human Papilloma Virus
HPV-Related Carcinoma
Vaccine Refusal
Parents
Program, Communication
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Mobile Phone-Based Web-Page: HPV vaccine
Brief summary:
Conditions
Human Papilloma Virus
HPV-Related Carcinoma
Vaccine Refusal
Parents
Program, Communication
Study ID
NCT04380623
Start date
Feb 15, 2021
Status verified date
Sep, 2021
Completion date
May 30, 2024
Anticipated
Primary completion date
May 30, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
244 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Mobile Phone-Based Web-Page: HPV vaccine
active comparator: Mobile Phone-Based Web-Page: Healthy Lifestyles
Interventions
Mobile Phone-Based Web-Page: HPV vaccine
Primary outcome measure
Locations
Meharry Medical College
Recruiting
Nashville, Tennessee, United States, 37208
Contacts
Sponsor
Meharry Medical College
Last update posted
Sep 8, 2021
Last verified
Sep, 2021
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Meharry Medical College on 2021-09-08.